ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,237Medicare Part D Prescriptions Filled, Including Refills

Rank: 127 out of 676

$707K Total Retail Price of All Prescriptions

Rank: 122 out of 676

578 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 578 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

10% of this provider’s 578 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 12,633 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
LEVOTHYROXINE SODIUM 561 515 1 7
OMEPRAZOLE 538 463 2 2
LISINOPRIL 522 495 3 5
METFORMIN HCL 514 438 4 8
SIMVASTATIN 377 332 5 6
AMLODIPINE BESYLATE 353 306 6 3
FUROSEMIDE 333 316 7 4
POTASSIUM CHLORIDE 322 293 8 9
MELOXICAM 295 268 9 13
METOPROLOL TARTRATE 250 224 10 22
HYDROCODONE-ACETAMINOPHEN 247 203 S3 11 1
GABAPENTIN 244 209 12 10
ALLOPURINOL 209 184 13 31
GLIMEPIRIDE 198 172 14 30
ATENOLOL 196 195 15 25
TRAMADOL HCL 192 183 16 19
NIFEDIPINE ER 174 149 17 100
HYDROCHLOROTHIAZIDE 173 137 18 12
WARFARIN SODIUM 169 134 19 18
NEXIUM 168 145 20 23
ZOLPIDEM TARTRATE 154 144 21 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 146 125 22 16
ATORVASTATIN CALCIUM 136 134 23 20
METOPROLOL SUCCINATE 135 130 24 14
CITALOPRAM HBR 133 117 25 17
NAMENDA 132 132 26 35
SERTRALINE HCL 130 123 27 26
AMITRIPTYLINE HCL 126 118 R 28 46
CARVEDILOL 122 92 29 15
TRIAMTERENE-HCTZ 121 101 30 43
CRESTOR 120 113 31 29
DONEPEZIL HCL 105 105 32 24
ESCITALOPRAM OXALATE 105 99 32 73
LOVASTATIN 103 79 34 33
SINGULAIR 102 87 35 80
CLONIDINE HCL 99 87 36 32
PRAVASTATIN SODIUM 89 76 37 11
PANTOPRAZOLE SODIUM 87 79 38 42
DIOVAN HCT 81 78 39 41
PAROXETINE HCL 78 65 40 65
RANITIDINE HCL 78 54 40 27
ESTRADIOL 76 62 R 42 109
PLAVIX 72 70 43 40
LANSOPRAZOLE 71 59 44 171
PROPRANOLOL HCL 71 71 44 120
GLIPIZIDE 69 59 46 81
GLYBURIDE-METFORMIN HCL 68 58 R 47 76
ISOSORBIDE MONONITRATE ER 67 54 48 54
SYNTHROID 67 67 48 48
CYMBALTA 67 49 48 47
DILTIAZEM 24HR CD 66 55 51 152
ACTOS 66 58 51 106
LIPITOR 64 57 53 94
AGGRENOX 63 51 54 147
DIOVAN 62 60 55 37
GEMFIBROZIL 62 55 55 137
DIGOXIN 62 58 55 52
HUMULIN 70-30 62 54 55 209
FLUTICASONE PROPIONATE 61 55 59 49
RAMIPRIL 61 58 59 86
HYDRALAZINE HCL 59 52 61 77
NOVOLIN 70-30 58 55 62 181
ROPINIROLE HCL 57 57 63 85
BENAZEPRIL HCL 56 28 64 58
ONGLYZA 55 43 65 178
MONTELUKAST SODIUM 54 42 66 150
TRAZODONE HCL 53 52 67 36
LYRICA 53 50 67 57
BUPROPION XL 53 53 67 227
QUETIAPINE FUMARATE 52 50 70 72
BYSTOLIC 52 40 70 96
CARBIDOPA-LEVODOPA 52 50 70 114
CLOPIDOGREL 52 52 70 28
CELEBREX 52 50 70 108
POLYETHYLENE GLYCOL 3350 51 51 75 56
LANTUS 51 43 75 55
VERAPAMIL ER 51 51 75 101
GLIPIZIDE ER 50 40 78 103
TAMSULOSIN HCL 50 46 78 38
NITROFURANTOIN MONO-MACRO 50 45 78 182
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.